Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy.
Publication
, Journal Article
Daubert, JP; Barnett, AS
Published in: JACC Heart Fail
August 2019
Duke Scholars
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
August 2019
Volume
7
Issue
8
Start / End Page
725 / 727
Location
United States
Related Subject Headings
- Primary Prevention
- Humans
- Heart Failure
- Denmark
- Defibrillators, Implantable
- Cardiomyopathies
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Daubert, J. P., & Barnett, A. S. (2019). Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy. JACC Heart Fail, 7(8), 725–727. https://doi.org/10.1016/j.jchf.2019.05.011
Daubert, James P., and Adam S. Barnett. “Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy.” JACC Heart Fail 7, no. 8 (August 2019): 725–27. https://doi.org/10.1016/j.jchf.2019.05.011.
Daubert JP, Barnett AS. Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy. JACC Heart Fail. 2019 Aug;7(8):725–7.
Daubert, James P., and Adam S. Barnett. “Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy.” JACC Heart Fail, vol. 7, no. 8, Aug. 2019, pp. 725–27. Pubmed, doi:10.1016/j.jchf.2019.05.011.
Daubert JP, Barnett AS. Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy. JACC Heart Fail. 2019 Aug;7(8):725–727.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
August 2019
Volume
7
Issue
8
Start / End Page
725 / 727
Location
United States
Related Subject Headings
- Primary Prevention
- Humans
- Heart Failure
- Denmark
- Defibrillators, Implantable
- Cardiomyopathies
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology